MRVI financials
Maravai LifeSciences (MRVI) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
MRVI income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $185.74M | $33.39M | -$6.74M | -$130.77M | -0.91 |
| 2024 | $259.19M | $108.31M | -$235.62M | -$144.85M | -1.05 |
| 2023 | $288.94M | $140.20M | -$31.65M | -$119.03M | -0.90 |
| 2022 | $883.00M | $714.04M | $574.22M | $220.21M | 1.67 |
| 2021 | $799.24M | $658.68M | $554.64M | $182.04M | 1.56 |
| 2020 | $284.10M | $204.45M | $119.90M | $76.89M | 2.36 |
- MRVI revenue was $185.74M in fiscal 2025, net income -$130.77M.
Updated 2026-11-07 11:56 UTC